Jivan Biologics empowers scientists with new insight by providing a full catalogue of splice variant products for all stages of the drug development pipeline from target discovery, target validation and functional genomics to predictive toxicology, personalized medicine and the search for clinical markers in blood. Available as a service since 2001 and as catalogue products since 2003, Jivan's flagship SpliceExpress™ arrays are the first commercial microarrays for alternative splicing. Jivan also leads with software for alternative splicing analysis and PCR primer sets for splice isoform detection.

• 06/17/08    Jivan Expands Business Focus to PCR, Software, Arrays for Alternative Splicing
• 05/19/08    US Patent and Trademark Office Orders Re-examination of Patent 6,881,571 in Litigation between Jivan and ExonHit
• 03/07/08    Jivan Awarded US Patent 7,340,349 for Splice Array Analysis
• 02/21/08    Extent and Diversity of Human Alternative Splicing Established by Complementary Database Annotation and Microarray Analysis
• 10/10/07    Jivan Enhances Splicing Analysis Software
• 06/21/07    Jivan Sponsors CHI's Beyond Genome Conference
• 01/15/07    Jivan Launches Software for Alternative Splicing Analysis
• 10/05/06     Jivan Awarded NIAAA Grant to Study Alcohol-Induced RNA Splicing
• 09/26/06     Profiling phosphodiesterase genes and splice isoforms. Biochem Biophys Res Commun
• 05/18/06     Jivan Launches Genome-Wide Mouse Splice Array
• 02/02/06     Jivan and NimbleGen Partner for Splice Array Market
• 11/30/05     Mouse and Rat Genome-Wide Exon Junction Arrays Launched by Jivan
• 11/14/05     First PCR Primers for Genome-Wide Alternative Splicing Launched by Jivan
• 10/14/05     Custom Exon Junction Arrays Offered by Jivan
• 07/11/05     Full Splice Variant Microarray Service Offered by Jivan and MOgene
• 06/02/05     Suite of Gene Family Splice Arrays Launched by Jivan Biologics
• 06/01/05     Splice Array for Clinical Markers in Blood Launched by Jivan Biologics
• 05/31/05     First Genome-Wide Splice Variant Arrays Launched by Jivan Biologics
• 12/09/04     Jivan Launches Cancer Splice Variant Microarray
• 07/06/04     Jivan and ArrayIt Release Splice Variant Microarray for Total Blood
• 12/12/03     Jivan Receives NIH Grant to Profile Alternative Splicing of Kinases in Cancer
• 11/18/03     Jivan Launches First Phosphodiesterase Splice Variant Array
• 05/16/03     Jivan Receives Phase I SBIR Grant for Cancer Diagnostics
• 11/22/02     Jivan Announces Cardiovascular Target Discovery Collaboration With Vasgene
• 06/26/02     Jivan Signs Target Validation Collaboration With Sugen
• 05/03/02     Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays

Founded in 2001, Jivan Biologics is a privately held C Corporation located in the San Francisco Bay Area. For investment information, please contact us.